{"id":741496,"date":"2023-03-21T08:04:38","date_gmt":"2023-03-21T12:04:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/"},"modified":"2023-03-21T08:04:38","modified_gmt":"2023-03-21T12:04:38","slug":"solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/","title":{"rendered":"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CHARLESTOWN, Mass., March  21, 2023  (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will participate in the BMO Biopharma Spotlight Series: Genetic Medicine Delivery in a panel discussion titled \u201cInnovative AAVs Targeting Diverse Tissues\u201d on Tuesday, March 28, 2023 at 9:00 AM ET.<\/p>\n<p align=\"justify\">The event will be made available live only to clients of BMO. Following the event, a replay of the panel discussion will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ojNPXbnLgDTOA-pUyxx23pcRbYf6G0MLP2uDgkqHEB7W2g6s2AwAXrmUDWlg4AdfdMyN5C1ppMNliiPiJAUKqesjcfh8j-5gCOq98TFSjHkx6srIzyvgQHi6IpB--j-P\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a> page of the Investors section of the Company website.<\/p>\n<p align=\"justify\">Institutional investors interested in meeting with management during the conference may reach out to their BMO representative.<\/p>\n<p>\n        <strong>About Solid Biosciences<\/strong>\n      <\/p>\n<p align=\"justify\">Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs, including SGT-003, a differentiated gene transfer candidate for the treatment of Duchenne, AVB-202-TT, a gene transfer candidate for the treatment of Friedreich\u2019s Ataxia, AVB-401 for BAG3 mediated dilated cardiomyopathy, and additional assets for the treatment of undisclosed cardiac diseases. Solid aims to be the center of excellence, bringing together those with expertise in science, technology, disease management and care. Patient-focused and founded by those directly impacted by Duchenne, Solid\u2019s mandate is to improve the daily lives of patients living with these devastating diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qLdzM_QDYqZrcGRmodmDMbcMHwjkIIQ_WPRD-i19A6haKw9NeG84m5ufPMxSRUuq73pdEtwvMQLH-BG_6g9Uuw==\" rel=\"nofollow noopener\" target=\"_blank\">www.solidbio.com<\/a>.<\/p>\n<p>\n        <strong>Solid Biosciences Investor Contact<\/strong>:<br \/>David Carey<br \/>FINN Partners<br \/>212-867-1768<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lsm0i9hDxJIVc58WhrXqdByZBl2CMQBT0_fkyvbODtBs11W7FfuootoLzlaNSfXxlB4-faZ5_8nRe5j9KwqJn1NkgFn0Dtlx4v3taCF9AMTiN7i2_Zaxg7xMYrhXbcY0\" rel=\"nofollow noopener\" target=\"_blank\">David.Carey@finnpartners.com<\/a><\/p>\n<p>\n        <strong>Solid Biosciences Media Contact<\/strong>:<br \/>Tim Palmer<br \/>Associate Director, Corporate Communications <br \/>607-760-4223<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ymLr0o7SgYlhwXqte0isvf3OJoxqWAu07RtZ6WloZnqWwfFy_KgOjkx-qFZtFe6Ji6g1EKOeJvVh8nxjcW1zag==\" rel=\"nofollow noopener\" target=\"_blank\">Tim@solidbio.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2M5YTM5MjQtMTkyNi00ZjhlLWEyMGEtYjJiYzZmNmJhYzU3LTExMDI3Njg=\/tiny\/Solid-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHARLESTOWN, Mass., March 21, 2023 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will participate in the BMO Biopharma Spotlight Series: Genetic Medicine Delivery in a panel discussion titled \u201cInnovative AAVs Targeting Diverse Tissues\u201d on Tuesday, March 28, 2023 at 9:00 AM ET. The event will be made available live only to clients of BMO. Following the event, a replay of the panel discussion will be available on the Events page of the Investors section of the Company website. Institutional investors interested in meeting with management during the conference may reach out to their BMO representative. About Solid &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-741496","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHARLESTOWN, Mass., March 21, 2023 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will participate in the BMO Biopharma Spotlight Series: Genetic Medicine Delivery in a panel discussion titled \u201cInnovative AAVs Targeting Diverse Tissues\u201d on Tuesday, March 28, 2023 at 9:00 AM ET. The event will be made available live only to clients of BMO. Following the event, a replay of the panel discussion will be available on the Events page of the Investors section of the Company website. Institutional investors interested in meeting with management during the conference may reach out to their BMO representative. About Solid &hellip; Continue reading &quot;Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-21T12:04:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery\",\"datePublished\":\"2023-03-21T12:04:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/\"},\"wordCount\":266,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/\",\"name\":\"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc=\",\"datePublished\":\"2023-03-21T12:04:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/","og_locale":"en_US","og_type":"article","og_title":"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery - Market Newsdesk","og_description":"CHARLESTOWN, Mass., March 21, 2023 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will participate in the BMO Biopharma Spotlight Series: Genetic Medicine Delivery in a panel discussion titled \u201cInnovative AAVs Targeting Diverse Tissues\u201d on Tuesday, March 28, 2023 at 9:00 AM ET. The event will be made available live only to clients of BMO. Following the event, a replay of the panel discussion will be available on the Events page of the Investors section of the Company website. Institutional investors interested in meeting with management during the conference may reach out to their BMO representative. About Solid &hellip; Continue reading \"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-21T12:04:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery","datePublished":"2023-03-21T12:04:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/"},"wordCount":266,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/","name":"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc=","datePublished":"2023-03-21T12:04:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTkzOSM1NDcyMTM2IzIwOTExOTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-at-bmo-biopharma-spotlight-series-genetic-medicine-delivery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=741496"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741496\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=741496"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=741496"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=741496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}